Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy

Otology and Neurotology

Volumn 30, Issue 5, 2009, Pages 619-624

  Crane, Benjamin T ^a   Minor, Lloyd B ^a   Della Santina, Charles C ^a   Carey, John P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gentamicin; Human; M ni re's disease; Middle ear exploration; Round window; Vertigo

Indexed keywords

GELFOAM; GENTAMICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCHLEA FENESTRA; EARDRUM PERFORATION; FEMALE; HUMAN; LABYRINTHECTOMY; MALE; MENIERE DISEASE; NERVE TRANSECTION; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT FAILURE; VERTIGO; VESTIBULAR NERVE;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; AUDIOMETRY; EAR, MIDDLE; FEMALE; GENTAMICINS; HUMANS; INJECTIONS; MALE; MENIERE DISEASE; MIDDLE AGED; ROUND WINDOW, EAR; SPEECH RECEPTION THRESHOLD TEST; TREATMENT FAILURE; TYMPANIC MEMBRANE;

EID: 68849085572     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181a66d2b     Document Type: Article

References (27)

1. Monsell EM, Balkany TA, Gates GA, et al. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. American Academy of Otolaryngology - Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-185
2. Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Ménière's disease: a meta-analysis. Laryngoscope 2004;114:2085-2091 (Pubitemid 39602470)
3. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 2004;25:544-552 (Pubitemid 39079778)
4. Kaplan DM, Nedzelski JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope 2000;110:1298-1305 (Pubitemid 30626096)
5. Perez N, Martin E, Garcia-Tapia R. Intratympanic gentamicin for intractable Ménière's disease. Laryngoscope 2003;113:456-464 (Pubitemid 36292870)
6. Minor LB. Intratympanic gentamicin for control of vertigo in Ménière's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-219
7. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Ménière's disease. Am J Otol 1998;19:435-442 (Pubitemid 28304383)
8. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Ménière's disease: a preliminary report. Laryngoscope 1997;107:49-55. (Pubitemid 27045194)
9. Colletti V, Carner M, Colletti L. Auditory results after vestibular nerve section and intratympanic gentamicin for Me7acute;nière's disease. Otol Neurotol 2007;28:145-151 (Pubitemid 46175113)
10. Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin North Am 2002;35:655-673
11. House JW, Hitselberger WE, McElveen J, et al. Retrolabyrinthine section of the vestibular nerve. Otolaryngol Head Neck Surg 1984;92:212-215
12. Glasscock ME 3rd, Thedinger BA, Cueva RA, et al. An analysis of the retrolabyrinthine vs. the retrosigmoid vestibular nerve section. Otolaryngol Head Neck Surg 1991;104:88-95.
13. Kemink JL, Telian SA, Graham MD, et al. Transmastoid labyrinthectomy: reliable surgical management of vertigo. Otolaryngol Head Neck Surg 1989;101:5-10.
14. Diaz RC, LaRouere MJ, Bojrab DI, et al. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy. Otol Neurotol 2007;28:74-86.
15. Nguyen KD, Minor LB, Della Santina CC, et al. Time course of repeated intratympanic gentamicin for Ménière's disease. Laryngoscope 2009;119:792-798
16. Carey JP, Minor LB, Peng GC, et al. Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Ménière's disease. J Assoc Res Otolaryngol 2002;3:430-443 (Pubitemid 36077392)
17. Lin FR, Migliaccio AA, Haslwanter T, et al. Angular vestibuloocular reflex gains correlate with vertigo control after intratympanic gentamicin treatment for Ménière's disease. Ann Otol Rhinol Laryngol 2005;114:777-785 (Pubitemid 41502380)
18. Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990; 116:424-427
19. Carey J. Intratympanic gentamicin for the treatment of Ménière's disease and other forms of peripheral vertigo. Otolaryngol Clin North Am 2004;37:1075-1090 (Pubitemid 39335774)
20. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-820 (Pubitemid 36539153)
21. Hill SL 3rd, Digges EN, Silverstein H. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière's disease. Ear Nose Throat J 2006;85:494, 496, 498.
22. Herr BD, Marzo SJ. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:527-531 (Pubitemid 40460877)
23. Smith BM, Myers MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979;87:888-891
24. Becvarovski Z, Bojrab DI, Michaelides EM, et al. Round window gentamicin absorption: an in vivo human model. Laryngoscope 2002;112:1610-1613 (Pubitemid 34977564)
25. Hellstrom S, Johansson U, Anniko M. Structure of the round window membrane. Acta Otolaryngol Suppl 1989;457:33-42.
26. Sahni RS, Paparella MM, Schachern PA, et al. Thickness of the human round window membrane in different forms of otitis media. Arch Otolaryngol Head Neck Surg 1987;113:630-634 (Pubitemid 17084556)
27. Alzamil KS, Linthicum FH Jr. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 2000;109:30-32